Vanda Pharmaceuticals Inc. (LON:0LKB)
4.400
-0.120 (-2.65%)
At close: Feb 21, 2025
Vanda Pharmaceuticals Revenue
In the year 2024, Vanda Pharmaceuticals had annual revenue of $198.77M USD with 3.18% growth. Vanda Pharmaceuticals had revenue of $53.19M in the quarter ending December 31, 2024, with 17.48% growth.
Revenue
$198.77M
Revenue Growth
+3.18%
P/S Ratio
n/a
Revenue / Employee
$540.14K
Employees
368
Market Cap
204.36M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 198.77M | 6.13M | 3.18% |
Dec 31, 2023 | 192.64M | -61.74M | -24.27% |
Dec 31, 2022 | 254.38M | -14.30M | -5.32% |
Dec 31, 2021 | 268.68M | 20.51M | 8.27% |
Dec 31, 2020 | 248.17M | 20.98M | 9.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |